Match!
Alain Hovnanian
Paris Descartes University
DermatologyImmunologyGeneticsMedicineBiology
182Publications
38H-index
6,956Citations
What is this?
Publications 191
Newest
#1Michael R. Williams (UCSD: University of California, San Diego)H-Index: 9
#2Laura Cau (UCSD: University of California, San Diego)
Last. Alexander R. Horswill (Anschutz Medical Campus)H-Index: 51
view all 13 authors...
Summary Netherton syndrome (NS) is a monogenic skin disease resulting from loss of function of lymphoepithelial Kazal-type-related protease inhibitor (LEKTI-1). In this study we examine if bacteria residing on the skin are influenced by the loss of LEKTI-1 and if interaction between this human gene and resident bacteria contributes to skin disease. Shotgun sequencing of the skin microbiome demonstrates that lesional skin of NS subjects is dominated by Staphylococcus aureus (S. aureus) and Staphy...
Source
#1Sabine Duchatelet (French Institute of Health and Medical Research)H-Index: 3
#2S. Miskinyte (French Institute of Health and Medical Research)H-Index: 1
Last. O. CogrelH-Index: 3
view all 27 authors...
Source
#2Sabine Duchatelet (Paris V: Paris Descartes University)H-Index: 6
Last. Thibault KervarrecH-Index: 5
view all 10 authors...
Source
#1Sonia Gaucher (Paris V: Paris Descartes University)H-Index: 2
#2Su M. Lwin ('KCL': King's College London)H-Index: 6
Last. Alain Hovnanian (Paris V: Paris Descartes University)H-Index: 38
view all 13 authors...
1 CitationsSource
#1Christina Has (University of Freiburg)
#2Johann W. BauerH-Index: 30
Last. M. Peter Marinkovich (Stanford University)H-Index: 44
view all 22 authors...
Source
#1April Zhang (MCW: Medical College of Wisconsin)
#2Sabine Duchatelet (French Institute of Health and Medical Research)H-Index: 3
Last. Alain Hovnanian (French Institute of Health and Medical Research)H-Index: 38
view all 13 authors...
Importance Olmsted syndrome is a rare and disabling genodermatosis for which no successful treatment is currently available. Objective To evaluate the clinical response to the mammalian target of rapamycin (mTOR) inhibitor sirolimus and/or the epidermal growth factor receptor (EGFR) inhibitor erlotinib among patients with Olmsted syndrome. Design, Setting, and Participants This case series focused on 4 children with treatment-refractory Olmsted syndrome. These children received treatments (initi...
Source
#1Romain Levy (French Institute of Health and Medical Research)H-Index: 4
#2Vivien Béziat (French Institute of Health and Medical Research)H-Index: 23
Last. Alain Hovnanian (French Institute of Health and Medical Research)H-Index: 38
view all 7 authors...
Source
#1Ann Louise Walker (GSK: GlaxoSmithKline)H-Index: 11
#2Alexis Denis (GSK: GlaxoSmithKline)H-Index: 8
Last. Alain Hovnanian (University of Paris)H-Index: 38
view all 20 authors...
Source
#1Christen L. EbensH-Index: 9
#2John MuzicH-Index: 64
Last. Jakub TolarH-Index: 46
view all 13 authors...
Source
#1A. Welfringer-Morin (Paris Diderot University)
#2Stéphanie Leclerc-Mercier (Necker-Enfants Malades Hospital)H-Index: 9
Last. E. Bourrat (Paris Diderot University)H-Index: 1
view all 5 authors...
Introduction L’epidermolyse bulleuse hereditaire (EBH) par mutation du gene codant pour la dystonine (DST) est une forme recessive exceptionnelle d’EB simple, d’identification recente. Nous rapportons un nouveau cas, diagnostique a l’occasion d’une gale. Observation Un garcon de 13 ans, malien, consultait pour une eruption bulleuse prurigineuse evoluant depuis 1 mois. L’examen montrait des bulles tendues eparses du tronc et des membres sans atteinte muqueuse, des cicatrices arrondies hypopigment...
Source
12345678910